Acupuncture in Medicine · 2016 · 43 citations · 18 references
MedicineEndocrinologyGynecologyReproductive EndocrinologyReproductive MedicineReproductive PhysiologyDiminished Ovarian ReserveGynecologic EndocrinologyHormonal EvaluationOvarian DisordersOvarian ReserveFollicle-stimulating Hormone AssessmentFollicle-stimulating Hormone TestingFollicle-stimulating Hormone TherapyHypothalamic-pituitary-ovarian Axis DysfunctionObservational Study EvaluationOvarian Reserve DepletionOvarian Reserve DiminutionPrimary Outcome Analysis
BACKGROUND: Effective methods for the treatment of reproductive dysfunction are limited. Previous studies have reported that acupuncture can modulate female hormone levels, improve menstrual disorders, alleviate depression and improve pregnancy rates. However, studies of acupuncture for diminished ovarian reserve (DOR) are lacking. OBJECTIVE: To carry out a prospective observational study aimed at assessing the effect of EA on the reproductive hormone levels of patients with DOR seeking fertility support and consider its safety. METHODS: Eligible patients with DOR received EA for 12 weeks: five times a week for 4 weeks followed by three times a week for 8 weeks. The primary outcome was the change in mean follicle-stimulating hormone (FSH) level at week 12. Mean luteinising hormone (LH) and serum oestradiol (E2) levels, FSH/LH ratios and symptom scale scores were simultaneously observed. RESULTS: Twenty-one patients with DOR were included in the final analysis. Mean FSH levels fell from 19.33±9.47 mIU/mL at baseline to 10.58±6.34 mIU/mL at week 12 and 11.25±6.68 mIU/mL at week 24. Change in mean FSH from baseline was -8.75±11.13 mIU/mL at week 12 (p=0.002) and -8.08±9.56 mIU/mL at week 24 (p=0.001). Mean E2 and LH levels, FSH/LH ratios and irritability scores were improved at weeks 12 and/or 24. Approximately 30% patients reported subjective increases in menstrual volume after treatment. CONCLUSIONS: EA may modulate reproductive hormone levels and the effects seem to persist for at least 12 weeks after treatment with no significant side effects. EA may improve the ovarian reserve of patients with DOR, though further research is needed. TRIAL REGISTRATION NUMBER: NCT02229604; Results.
18
Prognostic assessment of ovarian reserve
Richard T. Scott, Glen E. Hofmann · Fertility and Sterility · 1995 · 348 citations
Medicine, Gynecology, Oncology +14
Reproductive outcome in patients with diminished ovarian reserve
Andrew Levi, Mary F Raynault, Paul A. Bergh et al. · Fertility and Sterility · 2001 · 264 citations
Medicine, Endocrinology, Gynecology +14
Elizabeth Jedel, Fernand Labrie, Anders Odén et al. · American Journal of Physiology-Endocrinology and Metabolism · 2010 · 223 citations
Medicine, Endocrinology, Gynecology +17